Welcome Guest | Register / Login

Therapeutic Market Research Reports

Sort By
Title Published Price
Protagonist Therapeutics Inc (PTGX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Protagonist Therapeutics Inc (PTGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an...
Aug 2019 $ 125
Novelion Therapeutics Inc (NVLN) - Financial and Strategic SWOT Analysis Review
By GlobalData
Novelion Therapeutics Inc (NVLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an un...
Aug 2019 $ 125
Flexion Therapeutics Inc (FLXN) - Financial and Strategic SWOT Analysis Review
By GlobalData
Flexion Therapeutics Inc (FLXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unb...
Aug 2019 $ 125
Proteostasis Therapeutics Inc (PTI) - Financial and Strategic SWOT Analysis Review
By GlobalData
Proteostasis Therapeutics Inc (PTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an...
Aug 2019 $ 125
Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review
By GlobalData
Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and a...
Aug 2019 $ 125
Windtree Therapeutics Inc (WINT) - Financial and Strategic SWOT Analysis Review
By GlobalData
Windtree Therapeutics Inc (WINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an un...
Aug 2019 $ 125
Adhera Therapeutics (ATRX) - Strategic SWOT Analysis Review
By GlobalData
Adhera Therapeutics (ATRX) - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's...
Aug 2019 $ 125
Nuo Therapeutics Inc (AURX) - Strategic SWOT Analysis Review
By GlobalData
Nuo Therapeutics Inc (AURX) - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company'...
Aug 2019 $ 125
Trillium Therapeutics Inc (TRIL) - Financial and Strategic SWOT Analysis Review
By GlobalData
Trillium Therapeutics Inc (TRIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an un...
Aug 2019 $ 125
PTC Therapeutics Inc (PTCT) - Financial and Strategic SWOT Analysis Review
By GlobalData
PTC Therapeutics Inc (PTCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiase...
Aug 2019 $ 125
Addex Therapeutics Ltd (ADXN) - Financial and Strategic SWOT Analysis Review
By GlobalData
Addex Therapeutics Ltd (ADXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbia...
Aug 2019 $ 125
United Therapeutics Performance, Capabilities, Goals and Strategies
By Venture Planning Group
This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation to the ...
Aug 2019 $ 750
Neos Therapeutics Inc (NEOS) - Financial and Strategic SWOT Analysis Review
By GlobalData
Neos Therapeutics Inc (NEOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbias...
Jul 2019 $ 125
Miragen Therapeutics Inc (MGEN) - Financial and Strategic SWOT Analysis Review
By GlobalData
Miragen Therapeutics Inc (MGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unb...
Jul 2019 $ 125
Leap Therapeutics Inc (LPTX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Leap Therapeutics Inc (LPTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbias...
Jul 2019 $ 125
Sage Therapeutics Inc (SAGE) - Financial and Strategic SWOT Analysis Review
By GlobalData
Sage Therapeutics Inc (SAGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbias...
Jun 2019 $ 125
Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an ...
Jun 2019 $ 125
D. Western Therapeutics Institute Inc (4576) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary D. Western Therapeutics Institute Inc (DWTI) is a pharmaceutical product s developer. The company offers ophthalmic solution, WP-1303, H-1337, K-134 and DW-1002. It discovers and develops drugs for glaucoma. DWTI's ophthalmic sol...
Jun 2019 $ 300
Disruptor Profile: Pear Therapeutics, Inc.
By GlobalData
Disruptor Profile: Pear Therapeutics, Inc. Summary The report provides information and insights into Pear Therapeutics, Inc.'s, including - - Overview of the company and its product offering - Detailed insight in...
Jun 2019 $ 350
Calmare Therapeutics Inc (CTTC) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Calmare Therapeutics Inc (CTI) is a bio therapeutic company that offers pain mitigation and wound care technologies. The company provides non-pharmacological, non-addictive and non-invasive solution for chronic neuropathic pain a...
Jun 2019 $ 300
Repros Therapeutics Inc (RPRX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Repros Therapeutics Inc (Repros), formerly Zonagen Inc, a subsidiary of Allergan PLC, is a biopharmaceutical company that develops and markets drugs to treat hormonal and reproductive system disorders. The company's pipeline prod...
Jun 2019 $ 300
Capstone Therapeutics Corp (CAPS) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Capstone Therapeutics Corp (Capstone), formerly OrthoLogic Corp is a biotechnology company that develops and sells novel peptides and other molecules for helping patients with under-served medical conditions. The company develops...
Jun 2019 $ 300
Nabriva Therapeutics plc (NBRV) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Nabriva Therapeutics Plc (Nabriva) is a biopharmaceutical company that researches and develops antibiotics for the treatment of infections. The company's product candidate includes lefamulin, a pleuromutilin antibiotic, being dev...
Jun 2019 $ 300
Lumosa Therapeutics Co Ltd (6535) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Lumosa Therapeutics Co Ltd (Lumosa Therapeutics) develops drugs for the treatment of neurological and inflammatory diseases. The company's pipeline products include LT-1001, an analgesic injection for severe pain relief; and LT-3...
Jun 2019 $ 300
Arch Therapeutics Inc (ARTH) - Product Pipeline Analysis, 2019 Update
By GlobalData
Summary Arch Therapeutics Inc (Arch Therapeutics) is a medical device company. It develops self-assembling barrier technologies to improve interventional wound care outcomes. The company offers hemostasis and sealant products to seal and...
Jun 2019 $ 750
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy